NDUFS4 and Leigh syndrome: In 2013, Johnson and colleagues showed that intraperitoneal (i.p.)administration of high doses of rapamycin dramatically reduced the gliosis and the histopathological signs on a mouse model of Leigh syndrome due to mitochondrial complex I deficiency (Ndufs4−/− model), thus increasing the survival [1].